FDA Inspection 772106 — R. Phillip Dellinger, M.D.
The FDA completed an inspection of R. Phillip Dellinger, M.D. on Mar 20, 2012 in Camden, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Devices.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Mar 20, 2012
- Fiscal Year
- 2012
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Camden, NJ (United States)
Additional details
Clinical Investigator (CI)